TRASTUZUMAB DERUXTECAN for Neoplasm: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 43 adverse event reports in the FDA FAERS database where TRASTUZUMAB DERUXTECAN was used for Neoplasm.
Most Reported Side Effects for TRASTUZUMAB DERUXTECAN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 384 | 14.3% | 384 | 24 |
| Off label use | 258 | 9.6% | 36 | 71 |
| Nausea | 251 | 9.4% | 18 | 86 |
| Myelosuppression | 242 | 9.0% | 0 | 98 |
| Fatigue | 186 | 6.9% | 14 | 61 |
| Malignant neoplasm progression | 171 | 6.4% | 48 | 29 |
| Vomiting | 140 | 5.2% | 20 | 58 |
| Diarrhoea | 132 | 4.9% | 23 | 68 |
| Interstitial lung disease | 130 | 4.8% | 46 | 46 |
| Pneumonitis | 125 | 4.7% | 41 | 48 |
| Metastases to central nervous system | 103 | 3.8% | 22 | 25 |
| Toxicity to various agents | 97 | 3.6% | 2 | 15 |
| Asthenia | 95 | 3.5% | 13 | 40 |
| Disease progression | 87 | 3.2% | 29 | 14 |
| Dyspnoea | 77 | 2.9% | 23 | 38 |
Other Indications for TRASTUZUMAB DERUXTECAN
Her2 positive breast cancer (768)
Breast cancer metastatic (503)
Breast cancer (378)
Product used for unknown indication (362)
Her2 low breast cancer (110)
Breast cancer female (78)
Her2 negative breast cancer (57)
Chemotherapy (48)
Gastric cancer (37)
Invasive ductal breast carcinoma (24)
Other Drugs Used for Neoplasm
BEVACIZUMAB (502)
ATEZOLIZUMAB (404)
CYCLOPHOSPHAMIDE (385)
CARBOPLATIN (283)
PACLITAXEL (267)
NIVOLUMAB (219)
OXALIPLATIN (185)
PEMBROLIZUMAB (173)
LENALIDOMIDE (171)
DOXORUBICIN (150)